| risperidone / Generic mfg. |
NCT00515489: Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients |
|
|
| Terminated | N/A | 1882 | Europe | Risperidone | Janssen-Cilag, S.A. | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders | | 08/02 | | |
NCT00511628: Study on the Safety of Risperidone on Obese or Overweight Patients With Schizophrenia |
|
|
| Terminated | N/A | 1717 | Europe | Risperidone | Janssen-Cilag, S.A. | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder | | 01/03 | | |
NCT01234454: Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRI |
|
|
| Completed | N/A | 34 | US | Risperidone, risperidol, risperidal, Olanzapine, Zydis, Zyprexa | University of North Carolina, Chapel Hill | Schizophrenia | 06/05 | 12/07 | | |
NCT00174200: Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone |
|
|
| Completed | N/A | 20 | Canada, RoW | Risperidone 2 mg | Pfizer | Schizophrenia, Psychotic Disorders | | 05/06 | | |
| Completed | N/A | 120 | US | Risperidone, Olanzapine | Washington University School of Medicine, Janssen, LP | Schizophrenia, Type 2 Diabetes Mellitus | 10/06 | 10/06 | | |
NCT00287027: Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication |
|
|
| Terminated | N/A | 60 | US | Risperdal Long Acting Injectable Antipsychotic Medication | National Alliance on Mental Illness New Hampshire, Janssen Medical Affairs | Psychotic Disorders | | 12/06 | | |
| Completed | N/A | 2006 | RoW | Olanzapine, Risperidone, Haloperidol | Central Institute of Psychiatry, Ranchi, India | Metabolic Syndrome, Diabetes, Obesity | | 12/06 | | |
| Completed | N/A | 36 | Europe | quetiapine or olanzapine or risperidone or aripiprazole | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Schizophrenia | | 02/07 | | |
NCT00169988: Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms |
|
|
| Completed | N/A | 8 | US | risperidone, sertraline-primary | Northwell Health, Stanley Medical Research Institute, Janssen Pharmaceutica N.V., Belgium, Pfizer | Prodromal Schizophrenia, Psychotic Disorders | | 04/07 | | |
NCT00179062: Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder |
|
|
| Completed | N/A | 300 | US | olanzapine versus risperidone | Vanderbilt University | Schizophrenia, Schizoaffective Disorder, Depressive Disorder, Major, Bipolar Disorder | 06/07 | 06/07 | | |
NCT00644852: Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone |
|
|
| Completed | N/A | 342 | RoW | Retrospective chart review study | Johnson & Johnson Taiwan Ltd | Schizophrenia, Schizoaffective Disorder | 09/07 | 09/07 | | |
e-STAR, NCT00774085: An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable Risperidone |
|
|
| Completed | N/A | 408 | Europe | No intervention was given | Janssen Cilag N.V./S.A. | Schizophrenia | 12/07 | 12/07 | | |
NCT00686140: A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia |
|
|
| Completed | N/A | 200 | RoW | celecoxib, Celebrex(R), Placebo | Beijing HuiLongGuan Hospital, Stanley Medical Research Institute | Schizophrenia | 12/07 | 03/08 | | |
NCT00225498: Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade |
|
|
| Completed | N/A | 35 | US | ziprasidone vs risperidone or olanzapine, Geodon vs Risperdal or Zyprexa | Northwell Health | Schizophrenia | 10/08 | 10/08 | | |
| Completed | N/A | 100 | Canada | 2 antipsychotic medications (combinations of olanzapine, risperidone, clozapine, seroquel, haldol, perphenazine), main antipsychotic medication and placebo | Centre for Addiction and Mental Health, Canadian Psychiatric Research Foundation | Schizophrenia | 12/08 | | | |
NCT00312598: Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine |
|
|
| Completed | N/A | 30 | US | Aripiprazole, Abilify | University of North Carolina, Chapel Hill, Bristol-Myers Squibb | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Mood Disorders | 04/10 | 04/10 | | |
NCT01043250: Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients |
|
|
| Completed | N/A | 81 | RoW | | Samsung Medical Center, Ministry of Health & Welfare, Korea, Korea Otsuka Pharmaceutical Co., Ltd. | Schizophrenia, Schizoaffective Disorder | 04/10 | 12/10 | | |
NCT00206960: Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia |
|
|
| Completed | N/A | 56 | Europe | zuclopenthixol, Cisordinol, risperidone, Risperdal | Birte Glenthoj, University of Copenhagen, Glostrup University Hospital, Copenhagen, Rigshospitalet, Denmark, Hvidovre University Hospital, The Danish Medical Research Council, Copenhagen Hospital Corporation, Janssen-Cilag Ltd., The Novo Nordic Foundation | Schizophrenia | 09/10 | 09/10 | | |
NCT01026285: InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics |
|
|
| Completed | N/A | 1085 | Europe, RoW | Risperidone Long-Acting injectable or oral antipsychotics | Janssen-Cilag International NV | Schizophrenia | 03/12 | 03/12 | | |
NCT00629252: The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients |
|
|
| Terminated | N/A | 14 | Europe | Sertindole, Risperidone | University of Zurich, University Hospital of Psychiatry, Department Neuropsychopharmacology and Brain Imaging, H. Lundbeck A/S | Schizophrenia | 08/12 | 08/12 | | |
| Completed | N/A | 124 | RoW | Ginkgo biloba extract, EGb761, Placebo | Beijing HuiLongGuan Hospital | Schizophrenia | 06/13 | 08/13 | | |
NCT01181960: Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations |
|
|
| Completed | N/A | 1066 | US | Risperidone long acting injectable - New Starts, Risperidone long acting injectable - Continuous Users, Paliperidone Palmitate -New and Continuous Users, Other Antipsychotics - New Starts | Janssen Scientific Affairs, LLC | Schizophrenia, Bipolar Disorder | 11/13 | 11/13 | | |
NCT02192723: A Randomized Double-blind Trial With 6 Antipsychotic Drugs for Schizophrenia |
|
|
| Completed | N/A | 550 | RoW | Typical antipsychotic, Haldol and Trilafon, Risperidone, Risperdal, Olanzapine, Zyprexa, Quetiapine, Seroquel, Aripiprazole, Abilify, Ziprasidone, Geodon | Beijing HuiLongGuan Hospital | Schizophrenia | 06/14 | 06/14 | | |
NCT01698216: Switching From Consta® to Sustenna® in Patients With Schizophrenia |
|
|
| Completed | N/A | 50 | RoW | | Seoul National University Hospital | Schizophrenia | 05/15 | 05/15 | | |
| Completed | N/A | 50 | US | Risperidone, Risperdal, Omega-3 capsules, Omega-3, Placebo, Placebo capsules | Delbert Robinson, National Institute of Mental Health (NIMH), National Alliance for Research on Schizophrenia and Depression | Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, Bipolar Disorder, Psychosis NOS | 09/15 | 09/15 | | |
NCT01739127: Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI |
|
|
| Completed | N/A | 83 | Canada | Aripiprazole, ABILIFY, Risperidone/Quetiapine, Risperdal, Apo-risperidone, Seroquel, Apo-quetiapine | University of British Columbia, Bristol-Myers Squibb | Psychotic Disorders, Bipolar Disorder, Metabolic Syndrome X | 02/16 | 02/16 | | |
| Completed | N/A | 37 | US | | Massachusetts General Hospital, Novartis Pharmaceuticals | Schizophrenia, Serious Mental Illness, Metabolic Syndrome, Insulin Resistance, Glucose Metabolism | 05/16 | 05/16 | | |
NCT01878513: Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis |
|
|
| Completed | N/A | 88 | US | risperidone, Risperdal | Northwell Health | Schizophrenia, Schizoaffective Disorder, Psychotic Disorder Not Otherwise Specified, Severe Bipolar Disorder With Psychotic Features | 07/18 | 07/18 | | |
NCT02034253: Glutamate, Brain Connectivity and Duration of Untreated Psychosis |
|
|
| Completed | N/A | 134 | US | Risperidone, Risperdal | University of Alabama at Birmingham | Schizophrenia, Psychosis, Schizoaffective Disorder | 11/18 | 11/18 | | |
